Skip to main content

GLENVIEW CAPITAL MANAGEMENT, LLC

Position in MYGN — Myriad Genetics Inc

CIK 1138995 NEW YORK, NY

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$24,353,901
-$3,858,652 QoQ
Shares Held
5,411,978
+18.0% QoQ
Ownership
5.73%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GLENVIEW CAPITAL MANAGEMENT, LLC holds $177,124,194 across 3 Diagnostics & Research names. MYGN ranks #3 (13.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 MYGN
Myriad Genetics Inc
This page
5,411,978 $24,353,901

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,353,901 5,411,978
2026-01-06 $32,215,698 4,941,058
2025-12-31 $28,212,553 4,587,407
2025-09-30 $33,166,952 4,587,407
2025-06-30 $24,359,131 4,587,407
2025-03-31 $34,589,008 3,899,550
2024-12-31 $56,996,912 4,157,324
2024-09-30 $34,553,306 1,261,530
2024-06-30 $91,686,646 3,748,432
2024-03-31 $105,397,445 4,943,595
2023-12-31 $101,135,415 5,283,982
2023-09-30 $60,695,071 3,783,982
2023-06-30 $86,806,503 3,744,888
2023-03-31 $97,452,451 4,195,112
2022-12-31 $44,948,613 3,097,768
2022-09-30 $27,885,114 1,461,484
2022-06-30 $30,830,692 1,696,791
2022-03-31 $43,772,626 1,737,009
2021-12-31 $46,361,017 1,679,747
2021-09-30 $72,173,574 2,235,168
2021-06-30 $75,718,526 2,476,080
2021-03-31 $78,239,234 2,569,433
2020-12-31 $72,806,801 3,682,691
2020-09-30 $35,964,228 2,757,993
2020-06-30 $20,533,644 1,810,727
2020-03-31 $22,030,688 1,539,531